Positive Sequence Biology

company

About

Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
¥300M
Industries
Biopharma,Biotechnology,Genetics
Number Of Employee
1 - 10
Operating Status
Active

Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥300M
Positive Sequence Biology has raised a total of ¥300M in funding over 2 rounds. Their latest funding was raised on Nov 8, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 8, 2021 Series A ¥300M 1 Lilly Asia Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Positive Sequence Biology is funded by 1 investors. Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Lilly Asia Ventures Yes Series A